Role of bone marrow stromal cells in irradiation leukemogenesis

Acta Haematologica

Volumn 96, Issue 1, 1996, Pages 1-15

  Greenberger, Joel S ^a   Epperly, Michael W ^a   Jahroudi, Nadia ^a   Pogue Geile, Katherine L ^a   Berry, Lu Ann ^a   Bray, Jenifer ^a   Goltry, Kristin L ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Irradiation; Leukemia; Stromal cells

Indexed keywords

COLONY STIMULATING FACTOR 1; FIBRONECTIN; FLUORESCENT DYE; INTERLEUKIN 3; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; BONE MARROW CULTURE; CANCER CELL; CELL ADHESION; CELL CLONE; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC TRANSCRIPTION; HEMATOPOIESIS; HEMATOPOIETIC CELL; IONIZING RADIATION; LEUKEMOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY; RNA SPLICING; STEM CELL; STROMA CELL;

ANIMALS; BONE MARROW; BONE MARROW CELLS; CELL ADHESION; COCULTURE TECHNIQUES; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, EXPERIMENTAL; LEUKEMIA, RADIATION-INDUCED; MICE; MICE, INBRED CBA; RNA; STAINING AND LABELING; STROMAL CELLS; SUPEROXIDE DISMUTASE; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSGENES; TUMOR CELLS, CULTURED;

EID: 0029997709     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000203708     Document Type: Article

References (180)

1. Benton EV, Heinrich W, Parnell TA, Armstrong TW. Derrickson JH, Fishman GJ, Frank AL, Watts JW, Wiegel B: Ionizing radiation exposure of LDEF: Prerecovery estimates. Nucl Tracks Radiat Measur 1992;20:75-100.
2. Gardner MJ, Snee MP, Hall AJ, Powell CA, Downes S, Terell JD: Results of case-control study of leukemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria. Br Med J 1990;300:423-429.
3. Pastcanak D: Give us your spent fuel, your warheads: Curbing one nuclear hazard creates another. US News World Rep. Mar 20, 1995, pp 42-43.
4. Van Leeuwen FE, Chorus AMJ, vanden Belt-Duscbout AW, Hagenbeek A, Noyon R, van Kerkhoff EHM, Pinedo HM, Somers R: Leukemia risk following Hodgkin’s disease: Relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. J Clin Oncol 1994;12:1063-1073.
5. Van Leeuwen FE. Klokman WJ. Hagenbeek A, Noyon R, vanden Belt-Dusebout AW, van Kerkhoff EHM, van Heerde P, Somers R: Second cancer risk following Hodgkin’s disease: A 20-year follow-up study. J Clin Oncol 1994; 12: 312-325.
6. Biti G, Ccllai E, Magrini SM, Papi MG, Ponti-celli P. Boddi V: Second solid tumors and leukemia after treatment for Hodgkin’s disease: An analysis of 1121 patients from a single institution. Int J Radiat Oncol Biol Phys 1994;29: 25-31.
7. Nicholson HS, Fears TR, Byrne J: Death during adulthood in survivors of childhood and adolescent cancer. Cancer 1994;73:3094-3102.
8. Lehnert S: Gene induction and adaptive responses in irradiated cells: Mechanisms and clinical implications. Radiat Res 1995; 141: 108-123.
9. Weber MC, Tykocinski ML: Bone marrow stromal cell blockade of human leukemic cell differentiation. Blood 1994;83:2221-2229.
10. Metcalf D: The roles of stem cell self-renewal and autocrine growth factor production in the biology of myeloid leukemia. Cancer Res 1989: 49:2305-2311.
11. Wright SC, Zhong J, Larrick JW: Inhibition of apoptosis as a mechanism of tumor promotion. FASEBJ 1994;8:654-660.
12. Cline MJ: The molecular basis of leukemia. N Engl J Med 1994;330:328-333.
13. Seed TM, Kaspar LV: Changing patterns of radiosensitivity of hematopoietic progenitors from chronically irradiated dogs prone either to aplastic anemia or to myeloproliferative disease. Leuk Res 1990:14:299-307.
14. Silver A, Cox R: Telomere-like DNA polymorphisms associated with genetic predisposition to acute myeloid leukemia in irradiated CBA mice. Proc Natl Acad Sci USA 1993;90:1407-1410.
15. Greenberger JS: Ras mutations in human leukemia and related disorders. J Cell Cloning 1989;7:343-359.
16. Van der Loo JCM, Slieker WAT, Kieboom D, Ploemacher RE: Identification of hematopoietic stem cell subsets on the basis of their primi-tivencss using antibody ER-MP12. Blood 1995;85:952-962.
17. Ahuja H, Bar-Eli H, Arlin Z, Advani S, Allen S, Goldman J, Snyder A, Kline M: The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia. J Clin Invest 1991;87:2042-2445.
18. Cleary ML. Sklar J: Nucleotide sequence of a t(14; 18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 1985;82:7439-7443.
19. Lavau C, Dejean A: The t(15; 17) translocation in acute promyclocytic leukemia. Leukemia 1994;8(suppl 2):9-15.
20. Rogers SY, Bradbury D. Kozlowski R, Russell NH: Evidence for internal autocrine regulation of growth in acute myeloblastic leukemia cells. Exp Heamatol 1994;22:593-598.
21. Zhu YM. Bradbury DA, Keith FJ, Russell N: Absence of retinoblastoma protein expression results in autocrine production of interleukin-6 and promotes the autonomous growth of acute myeloid leukemia blast cells. Leukemia 1994;8: 1982-1988.
22. Macmillan EM, Gonda TJ: Murine myeloid cells transformed by myb require fibroblast-derived or autocrine growth factors in addition to granulocyte-macrophage colony-stimulating factor for proliferation. Blood 1994;83:209-216.
23. Ozaki S, Wolfenbarger D, deBram-Hart M, Ka-nangat S, Weiss DT, Solomon A: Characterization of a novel interlcukin-6 autocrine-dependent human plasma cell line. Leukemia 1994;8: 2207-2213.
24. Treisman J. Hwu P, Minamoto S, Shafer GE, Cowherd R, Morgan RA, Rosenberg SA: Inter-leukin-2-transduced lymphocytes grow in an autocrine fashion and remain responsive to antigen. Blood 1995;85:139-145.
25. Baserga R: Oncogenes and the strategy of growth factors. Cell 1994;79:927-930.
26. Sirard C, Laneuville P, Dick JE: Expression of bcr/abl abrogates factor-dependent growth of human hematopoietic M07E cells by an autocrine mechanism. Blood 1994;83:1575-1585.
27. Guadagno TM, Ohtsubo M, Roberts JM, As-soian RK: A link between cyclin A expression and adhesion-dependent cell cycle progression. Science 1993;262:1572-1575.
28. Chen AR. Rohrschneider LR: Mechanism of differential inhibition of factor-dependent cell proliferation by transforming growth factor-pl: Selective uncoupling of fms from myc.Blood 1993:8:2539-2546.
29. Eaves CJ, Cashman JD. Wolpe SD, Eaves AC: Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein-la, an inhibitor of primitive normal hematopoietic cells. Proc Natl Acad Sci USA 1993:90:12015.
30. Heinrich MC, Dooley DC, Keeble WW: Transforming growth factor p I inhibits expression of the gene products for Steel factor and its receptor (c-kit).Blood 1995;85:1769-1780.
31. K|r| in C3H 10T1/2 mouse fibroblasts. Cancer Res 1995:55:1413-1416.
32. Kostenuik PJ, Orr FW, Singh G: Transforming growth factor-p stimulates the intcgrin-mc-diatcd adhesion of prostatic carcinoma cells to bone cell matrix. Proc Am Assoc Cancer Res 1995:36:86.
33. Kostenuik PJ, Orr FW, Singh G: TGF-p stimulates the «:Pi intcgrin-mediatcd adhesion of PC-3 prostatic carcinoma cells to type I collagen. Proc Am Assoc Cancer Res 1995:36:62.
34. Weiss HA, Darby SC. Feam T, Doll R: Leukemia mortality after X-ray treatment for ankylosing spondylitis. Radiat Res 1995;142:1-11.
35. Anscher MS, Crocker IR, Jirtle RL: Transform-ing growth factor-pl expression in irradiated liver. Radiat Res 1990;122:77-85.
36. Hussain SP, Aguilar F. Amstad P, Cerutti P: Oxy-radical induced mutagenesis of hotspot codons 248 and 249 of the human p53 gene. Oncogene 1994:9:2277-2281.
37. Strasser A, Harris AW, Jacks T, Cory S: DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by bcl-2.Cell 1994:79:329-339.
38. Rosselli F, Ridet A, Soussi T, Duchaud E, Ala-petite C, Moustacchi E: p53-dcpendent pathway of radio-induced apoptosis is altered in Fanconi anemia. Oncogene 1995;10:9-17.
39. Mothersill C, Harney J, Seymour CB: Induction of stable p53 oncoprotein and of c-myc overexpression in cultured normal human urocpithelium by radiation and N-nitrosodi-ethanolaminc. Radiat Res 1994;138:93-98.
40. Blaydes JP, Schlumberger M, Wynford-Thom-as D. Wyllie FS: Interaction between p53 and TGFpl in control of epithelial cell proliferation. Oncogene 1995;10:307-317.
41. Perry ME, Piette J, Zawadzki JA, Harvey D, Levine AJ: The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc Natl Acad Sci USA 1993:90:11623-11627.
42. Harada H, Kondo T, Ogawa S, Tamura T, Kitagawa M, Tanaka N, Lamphier S. Hirai H, Taniguchi T: Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia: A possible mechanism of tumor suppressor inactivation. Oncogene 1994:9:3313-3320.
43. Hill CS, Treisman R: Transcriptional regulation by extracellular signals: Mechanisms and specificity. Cell 1995:80:199-211.
44. Marshall CJ: Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 1995:80:179-185.
45. Neta R. Oppcnheim JJ: Cytokines in therapy of radiation injury. Blood 1988:72:1093-1095.
46. Fishel R. Lescoe MK, Rao MRS, Copeland NG, Jenkins NA, Garber J. Kane M, Kolodncr R: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993:75:1027-1038.
47. Leach FS, Nicolaidcs NC, Papadopulos N: Mutations of a mutS homology in hereditary nonpolyposis colorectal cancer. Cell 1993;75: 1215-1225.
48. Greenberger JS: Is the marrow stroma of AML patients a ‘leukemic’ stroma? Exp Hematol 1992;20:1041-1042.
49. Duhrsen U, Metcalf D: Effects of irradiation of recipient mice on the behavior and leukemo-genic potential of factor-dependent hematopoieticcell lines. Blood 1990;75:190-197.
50. Tcrzaghi-Howe M: Interactions between cell populations influence expression of the transformed phenotype in irradiated rat tracheal epithelial cells. Radiat Res 1990:121:242-247.
51. Meijne EIM. Ploemacher RE, Vos O, Huis-kamp R: The effects of graded doses of 1 McV fission neutrons or X-rays on the murine hematopoietic stroma. Radiat Res 1992:131:302-308.
52. Grande T, Buercn JA: Involvement of the bone marrow stroma in the residual hematopoietic damage induced by irradiation of adult and young mice. Exp Hematol 1994:22:1283-1287.
53. Wegrowski J, Lefaix JL, Lafuma C: Accumulation of glycosaminoglycans in radiation-induced muscular fibrosis. Int J Radiat Biol 1992:61:685-693.
54. Ishihara H, Tsuneoka K. Borrisov Dimchev A, Shikita M: Induction of the expression of the interleukin-1β gene in mouse spleen by ionizing radiation. Radiat Res 1993:133:321-326.
55. Yang FT, Lord BI, Hendry JH: Gamma-irra-diation of the fetus damages the developing hemopoietic microenvironment rather than the hemopoietic progenitor cells. Radiat Res 1995:141:309-313.
56. Anderson MT, Staal FJT, Gitler C, Herzenberg LA, Herzenberg LA: Separation of oxidant-initiated and redox-regulated steps in the NF-kB signal transduction pathway. Proc Natl Sci USA 1994;91:11527-11531.
57. Edvardsen K. Chen W. Rucklidge G, Walsh FS, Obrink B. Bock E: Transmembrane neural cell-adhesion molecule (NCAM), but not gly-cosyl-phosphatidylinositol-anchored NCAM, down-regulates secretion of matrix metallopro-teinases. Proc Natl Acad Sci USA 1993:90: 11463-11467.
58. Duhrsen U, Metcalf D: A model system for leukemic transformation of immortalized hemopoietic cells in irradiated recipient mice. Leukemia 1988;2:329-333.
59. Naparstek E. Donnelly T, Kasc K, Greenberger JS: Biologic effects of in vitro X-irradiation of murine long-term bone marrow cultures on the production of granulocyte-macrophage colony stimulating factors. Exp Hematoll985;13:701-708.
60. Naparstek E, Donnelly T. Shadduck R. Wagner K, Kase KR, Greenberger JS: Persistent production of granulocyte-macrophage colony-stimulating factor (CSF-1) by cloned bone marrow stromal cell line D2XRII after X-irradia-tion. J Cell Physiol 1986;126:407-417.
61. Naparstek E, FitzGerald TJ. Sakakceny MA. Klassen V, Pierce JH, Woda B. Falco J, Fitzgerald S. Nizin P, Greenberger JS: Induction of malignant transformation of cocultivated hematopoietic stem cells by X-irradiation of murine bone marrow stromal cells in vitro. Cancer Res 1986:46:4677-4684.
62. Naparstek E, Pierce J, Metcalf D, Shadduck R, Ihle J. Leder A, Sakakceny MA. Wagner K, Falco J, FitzGerald TJ. Greenberger JS: Induction of growth alterations in factor-dependent hematopoietic progenitor cell lines by cocultivation with irradiated bone marrow' stromal cell lines. Blood 1986;67:1395-1403.
63. Naparstek E, Anklesaria P. FitzGerald TJ, Sa-kakeeny MA, Greenberger JS: Morphology of cell-to-cell contact between X-irradiated plateau phase bone marrow stromal cell lines and cocultivated factor-dependent cell lines leading to leukemogenesis in vitro. Scanning Microsc 1987;1:247-253.
64. Greenberger JS, FitzGerald TJ, Klassen V, Anklesaria P. Bushnell D, Kase K, Sakakceny MA: Alteration in hematopoietic stem cell seeding and proliferation by low dose rate irradiation of bone marrow stromal cells in vitro. Int J Radiol Oncol Biol Phys 1988:14:85-94.
65. Greenberger JS, Wright E, Henault S, Sakakee-ny MA. Anklesaria P. FitzGerald TJ, Wheaton M. Kase K. Kuzawa D: Hematopoietic stem cell and marrow stromal cell specific requirements for gamma-irradiation leukemogenesis in vitro. Exp Hematol 1990; 18:408-416.
66. Greenberger JS: Toxic effects on the hematopoietic microenvironment. Exp Hematol 1991; 19:1101-1109.
67. Greenberger JS, Leif J, Crawford D, Anklesaria P, English D. Sakakeeny MA, Rubin JR. Pierce PH. Shadduck RK, FitzGerald TJ: Humoral and cell surface interactions during gamma-irradiation leukemogenesis in vivo. Exp Hematol 1991;20:92-102.
68. Greenberger JS, Sakakeeny M. Leif J, Anklesaria P. Pierce JH, Shadduck RK: Expression of M-CSF and its receptor (c-fms) by factor dependent hematopoietic progenitor cell lines evolving from cocultivation with gamma irradiated marrow stromal cell lines. Leukemia 1991;6:626-633.
69. Rugal V, Dudin M. Rakov A, Abdulkadyrov K: Hematopoietic microenvironment of bone marrow in children from the zone of Chernobyl accident. Exp Hematol 1993;21:1051.
70. Browne PV, Lawler M, Humphries P. McCann SR: Donor cell leukemia after bone marrow transplantation for severe aplastic anemia. N Engl J Med 1991;325:710-713.
71. Bendall LJ, Daniel A, Kortlcpcl K, Gottlieb DJ: Bone marrow adherent layers inhibit apo-ptosis of acute myeloid leukemia cells. Exp Hematol 1994;22:1252-1260.
72. Preston DL, Kusumi S, Tomonaga M. Izumi S, Ron E, Kuramoto A. Kamada N, Dohy H, Matsui T, Nonaka H, Thompson DE, Soda M, Mabuchi K: Cancer incidence in atomic bomb survivors. Ill: Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res 1994; 137(suppl):68-97.
73. Askew DS, Ashmun RA. Simmons BC, Cleveland JL: Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 1991;6:1915-1922.
74. Tucker MA, Coleman CN, Cox RS: Risk of second cancers after treatment of Hodgkin’s disease. N Engl J Med 1988;318:76-81.
75. Andersson M, Carstensen B, Visfcld J: Leukemia and other related hematological disorders among Danish patients exposed to thorotrast. Radiat Res 1993;134:224-233.
76. Ben-Neriah Y, Daley GQ, Mes-Masson AM, Witte ON, Baltimore D: The chronic myelogenous leukemia specific p210 protein is the product of the bcr/abl hybrid gene. Science 1986;233:212-215.
77. Uchida N, Aguila HL, Fleming WH, Jerabek L, Weissman IL: Rapid and sustained hematopoietic recovery in lethally irradiated mice transplanted with purified Thy-1.1, Lin-, Sca-1+ hematopoietic stem cells. Blood 1994;83: 3758-3779.
78. Berardi AC, Wang A, Levine JD, Lopez P, Scadden DT: Functional isolation and characterization of human hematopoietic stem cells. Science 1995;267:104-106.
79. Giralt S, Champlin RE: Leukemia relapse after allogeneic bone marrow transplantation: A review. Blood 1994;84:3603-3612.
80. 1 positive leukemia in donor cells after marrow transplantation for chronic granulocytic leukemia: Confirmation of the donor origin of cells by microsatellite studies. Blood 1992;79:2803-2805.
81. McCann SR, Lawler M, Bacigalupo A: Recurrence of Philadelphia positive leukemia in donor cells after marrow transplantation for chronic granulocytic leukemia. Leuk Lymphoma 1993;10:419-425.
82. Socie G. Henry-Amar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P. McCann SR, Frickhofen N, Van’T Veer-Korthof E, Gluckman E: Malignant tumors occurring after treatment of aplastic anemia. N Engl J Med 1993:329:1152-1157.
83. Bourette RP, Mouchiroud G, Ouazana R, Morle F, Godet J, Blanchet JP: Expression of human colony-stimulating factor-1 (CSF-1) receptor in murine pluripotent hematopoietic NSF-60 cells induces long-term proliferation in response to CSF-1 without loss of crythroid differentiation potential. Blood 1993;8:2511-2520.
84. McArthur GA, Metcalf D, Rakar S, Johnson GR: Overexpression of c-finis in the myeloid cell line FDC-P1 induces transformation that dissociates M-CSF-induced proliferation and differentiation. Leukemia 1995;9:68-76.
85. Ucmura N, Ozawa K, Takahashi K, Tojo A, Tani K. Harigaya K, Suzu S, Motoyoshi K, Matsuda H, Yagita H, Okumura K, Asano S: Binding of membrane-anchored macrophage colony stimulating factor (M-CSF) to its receptor mediates specific adhesion between stromal cells and M-CSF receptor-bearing hematopoietic cells. Blood 1993;82:2634-2640.
86. Anklesaria P, Kase KR, Glowacki J, Holland CH. Sakakecny MA, Wright JH, FitzGerald TJ, LeeCYL, Greenberger JS: Engraftment of a clonal bone marrow stromal cell line in vivo stimulates hematopoietic recovery from total body irradiation. Proc Natl Acad Sci USA 1987;84:7681-7685.
87. Greenberger JS, Anderson J, Boggs S, Cronkite EP: Biologic properties of hematopoietic progenitor cells and stromal cells in long-term bone marrow cultures derived from irradiated leukemia-prone CBA/Ca mice. Leukemia, in press.
88. Anklesaria P. Teixido J, Laiho M, Pierce J, Greenberger JS, Massaguc J: Cell homing and proliferation mediated by membrane TGF-a binding to EGF receptor. Proc Natl Acad Sci USA 1990;87:3289-3293.
89. Epperly MW, Fisher AM, Berry LA, Cote GJ, Goldring SM, Glowacki J, Greenberger JS: Induction of binding of clonal mouse hematopoietic progenitor cell line 32D cl 3 overexpressing a transgene for the human calcitonin receptor to clonal GPIa murine bone marrow stromal cells. Exp Hematol 1995;23:750.
90. FitzGerald TJ, Henault S, Sakakecny MA, San-tucci MA, Pierce JH, Anklesaria P, Kase K. Lovington K, Greenberger JS: Resistance of hematopoietic stem cells to X-irradiation at clinical low-dose rate is induced by several classes of oncogenes. Radiat Res 1990; 122:44-53.
91. Neben S, Anklesaria P, Greenberger JS, Mauch P: Quantitation of murine hematopoietic stem cells in vitro by limiting dilution analysis of cobblestone area formation on a clonal stromal cell line. Exp Hematol 1993;21:438-444.
92. Boivin GP, O’Toole BA, Orsmby IE, Diebold RJ, Eis MJ, Doetschman T, Kier AB: Onset and progression of pathological lesions in transforming growth factor-ßl-deficient mice. Am J Pathol 1995;146:276-288.
93. Kulkami AB, Ward JM, Yaswen L, Mackall CL, Bauer SR. Huh CG, Gress RF. Karlsson S: Transforming growth factor-ßl null mice: An animal model for inflammatory disorders. Am J Pathol 1995;146:264-275.
94. Epperly M, Santucci MA, Reed J, Shields D, Halloran A, Greenberger JS: Expression of the human BCL-2 transgene increases the radiation resistance of a hematopoietic progenitor cell line. Radiat Oncol Invest 1994,2:77-84.
95. Epperly MA, Berry' LA, Halloran A, Griffin J, Sherr J, Greenberger JS: Increased irradiation resistance in 32D cl 3 hematopoietic progenitor cells overexpressing D-type cyclins. Radiat Res 1995;143:245-254.
96. Yamazaki K, Roberts RA, Spooncer E, Dexter TM, Allen TD: Cellular interactions between 3T3 cells and interleukin-3-dependent mullipotent haemopietic cells: A model system for stromal-cell-mediated haemopoiesis. J Cell Physiol 1989;139:301-312.
97. Eaves CJ, Barnett MJ, Eaves AC: In vitro culture of bone marrow cells for autografting in CML. Leukemia 1993;7(suppl): 126.
98. Greenberger JS: Long term hematopoietic cultures; in Golde D (ed): Methods in Hematology. New York, Churchill Livingstone. 1984. vol 11, PP 203-243.
99. FitzGerald TJ, Anklesaria P, Le D, Sakakecny MA, Kase K, Greenberger JS: Radiosensitivity of cloned permanent murine bone marrow stromal cell lines: Non-uniform effect of low-dose rate. Exp Hematol 1988; 16:820-827.
100. Breems DA, Blokland EAW, Neben S, Ploe-macher RE: Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cell assay. Leukemia 1994;8:1095-1104.
101. Issaad C, Croisille L, Katz A, Vainchenker W, Coumombel L: A murine stromal cell line allows the proliferation of very primitive human CD34++/CD38- progenitor cells in long term culture and semisolid assays. Blood 1993;81:2916-2924.
102. Sutherland HJ, Eaves CJ, Eaves AC, Dra-gowska W, Lansdorp PM: Characterization and partial purification of human marrow cells capable of initiating long-term hemato-poiesis in vitro. Blood 1989,74:1563.
103. Rebel VI, Dragowska W, Eaves CJ, Humphries RK, Lansdorp PM: Amplification of Sca-1+, Lin-, WGA+ cells in serum-free cultures containing Steel factor, interleukin-6 and erythropoietin with maintenance of cells with long term in vivo reconstituting potential. Blood 1994;83:128-136.
104. Pogue-Geile K, Sakakecny MA, Greenberger JS: The effect of ionizing irradiation on multiple M-CSF RNA transcripts. Exp Hematol 1994;22:769.
105. Goltry KL, Pogue-Geile KL, Greenberger JS: Identification of genes expressed in a factor-independent clonal subline derived from the hematopoietic progenitor cell line FDC-P1. Exp Hematol 1994;22:749.
106. Liesveld JL, Frediani KE, Harbol AW, Di-Persio JF, Abboud CN: Characterization of the adherence of normal and leukemic CD34+ cells to endothelial monolayers. Leukemia 1994;8:2111-2117.
107. Manabc A, Murti KG, Coustan-Smith E, Ku-magai MA, Bchm FG, Raimondi SC, Campa-na D: Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells. Blood 1994:83: 758-766.
108. Sato N, Sawada K, Koizumi K, Tarumi T, Leko M, Yasukouchi T, Yamaguchi M, Taka-hashi TA, Sckiguchi S, Koike T: In vitro expansion of human peripheral blood CD34+ cells. Blood 1993;82:3600-3609.
109. Arnold JT. Barber L, Bcrtoncello I, Williams NT: Modified thrombopoietic response to 5-FU in mice following transplantation of Lin, SCA-1+ bone marrow cells. Exp Hematol 1995;23:161-167.
110. Murray L, Chen B, Galy A, Chen S, Tushinski R. Uchida N, Ncgrin R, Tricot G, Jagannath S, Vesole D. Barlogie B, Hoffman R. Tsuka-moto A: Enrichment of human hematopoietic stem cell activity in the CD34+ Thy-1+ lin- subpopulation from mobilized peripheral blood. Blood 1995;85:368-378.
111. Mayani H, Dragowska W, Lansdorp PM: Characterization of functionally distinc subpopulations of CD34+ cord blood cells in serum-free long term cultures supplemented with hematopoietic cytokines. Blood 1993; 82:2664-2672.
112. Xiao M, Broxmeyer HE. Horie M, Grigsby S, Lu L: Extensive proliferative capacity of single isolated CD34+++ human cord blood cells in suspension culture. Blood Cells 1994;20: 455-467.
113. Moore MAS. Hoskins I: Ex vivo expansion of cord blood-derived stem cells and progenitors. Blood Cells 1994;20:468-481.
114. Pogue-Geilc KL, Sakakeeny MA, Panza JL. Sell SL, Greenberger JS: Cloning and expression of unique murine macrophage colony stimulating factor transcripts. Blood 1995:85: 3478-3486.
115. Cacercs JF, Stamm S, Helfman DM, Krainer AR: Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 1994,265:1706-1710.
116. Harris CA, Andnuk PJ, Cline S, Chan HK, Natarajan A, Siekierka JJ, Goldstein G: Three distinct human thymopoietins are derived from alternatively spliced RNAs. Proc Natl Acad Sci USA 1994;91:6283-6287.
117. Lyman SD, James L, Escobar S, Downey H, de Vries P. Brasel K, Stocking K, Beckmann MP, Copeland NG, Cleveland LS, Jenkins NA, Belmont JW, Davison BL: Identification of soluble and membrane-bound isoforms of the murine flt3 ligand generated by alternative splicing of mRNAs. Oncogene 1995; 10: 149-157.
118. Ciossck T, Millauer B, Ullrich A: Identification of alternatively spliced mRNAs encoding variants of MDK1, a novel receptor tyrosine kinase expressed in the murine nervous system. Oncogene 1995;10:97-109.
119. Constine L, Liesveld J, Martin B, Rubin P: Radiation-induced release of select cytokines from human bone marrow. Int J Radiat Oncol Biol Phys 1994;30(suppl 1):300
120. Brach MA, Gruss HJ, Kaisho T, Asano Y, Hirano T, Herrmann F: Ionizing radiation induces expression of interleukin 6 by human fibroblasts involving activation of nuclear factor-xB. J Biol Chem 1993:268:8466-8472.
121. Singh SP, Lavin MF: DNA-binding protein activated by gamma radiation in human cells. Mol Cell Biol 1990;10:5279-5285.
122. A and mitogen-activated serine/ threonine protein kinases by ionizing radiation. Proc Natl Acad Sci USA 1994:91:5416-5420.
123. Peter RU, Bectz A, Ried C, Michel G, van Beuningen D. Ruzicka T: Increased expression of the epidermal growth factor receptor in human epidermal kcratinocytes after exposure to ionizing radiation. Radiat Res 1993: 136:65-70.
124. Schmidt-Ullrich RK, Valerie KC, Chan W. McWilliams D: Altered expression of epidermal growth factor receptor and estrogen receptor in MCF-7 cells after single and repeated radiation exposures. Int J Radiat Oncol Biol Phys 1994;29:813-819.
125. Verheij M, Dewit LGH, Boomgaard MN, Brinkman HJM, van Mourik JA: Ionizing radiation enhances platelet adhesion to the extracellular matrix of human endothelial cells by an increase in the release of von Wille-brand factor. Radiat Res 1994:137:202-207.
126. Jahroudi N, Lynch DC: Endothelial-cell-spc-cific regulation of von Willebrand factor gene expression. Mol Cell Biol 1994:14:999-1008.
127. Zhou Q, Zhao Y, Li P, Bai X, Ruan C: Thrombomodulin as a marker of radiation-induced endothelial cell injury. Radiat Res 1992;131:285-289.
128. Winkles JA, Pcifley KA, Friesel RE: Tumor promoters induce basic fibroblast growth factor gene expression in human dermal fibroblasts. Cancer Res 1992;52:1040-1043.
129. Barcellos-Hoft MH: Radiation-induced transforming growth factor p and subsequent extracellular matrix reorganization in murine mammary gland. Cancer Res 1993;53:3880-3886.
130. Boothman DA, Ixe IW, Sahijdak WM: Isolation of an X-ray-responsive element in the promoter region of tissue-type plasminogen activator: Potential uses of X-ray-rcsponsive elements for gene therapy. Radiat Res 1994; 138(suppl):68-71.
131. Raymond J, Yoon SC, Ts’Ao CH: Stimulation of radiation-impaired plasminogen activator release by phorbol ester in aortic endothelial cells. Proc Soc Exp Biol Med 1990:195: 213-220.
132. Boothman DA, Davis TW, Sahijdak WM: Enhanced expression of thymidine kinase in human cells following ionizing radiation. Int J Radiat Oncol Biol Phys 1994;30:391-398.
133. Brenner DJ, Sachs RK: Chromsomal ‘fingerprints’ of prior exposure to densely ionizing radiation. Radiat Res 1994;140:134-142.
134. Landberg CW, Haucr-Jensen M, Sung CC, Kane CJM: Expression of fibrogenic cytokines in rat small intestine after fractionated irradiation. Radiother Oncol 1994;32:29-36.
135. Jung M, Kondratyev AD, Dritschilo A: Elongation factor 18 is enhanced following exposure to ionizing radiation. Cancer Res 1994; 54:2541-2543.
136. Chen H, Rupa DS, Tomar R, Eastmond DA: Chromosomal loss and breakage in mouse bone marrow and spleen cells exposed to benzene in vivo. Cancer Res 1994;54:3533-3539.
137. Ishiltara H, Yoshida K, Nemoto K, Tsuneoka K, Shikita M: Constitutive ovcrcxpression of the c-fos gene in radiation-induced granulocytic leukemia in mice. Radiat Res 1993:135: 394-399.
138. Boothman DA, Majmudar G, Johnson T: Immediate X-ray-inducible responses from mammalian cells. Radiat Res 1994; 138 (suppl):44-46.
139. Kyriakis JM, Banerjee P. Nikolakaki E, Dai T, Rubie EA, Ahmad MF. Avruch J, Wood-gett RJ: The stress-activated protein kinase subfamily of c-jun kinases. Nature 1994:369: 156-160.
140. Behrends U, Peter RU. Hintermclcr-Knabc R, Eissner G. Degitz K, Hoffmann-Fezer G, Schultz-Hector S: Ionizing radiation induces ICAM-1 in human cells and organ cultures in vitro as well as in murine organs in vivo. Radiat Res 1994;139:14-232.
141. Hallahan DE, Kuchibhotla J, Clark E, Gcwcr-ty BL: The E-selectin promoter is a novel radiation-induced gene in endothelial cells. Proc Am Assoc Cancer Res 1995,36:605.
142. Lamond JP, Kirwin R. Wall ME, Boothman DA: Topoisomerase I inhibitors potentiate radiation lethality in vitro. Proc Am Assoc Cancer Res 1995:36:441.
143. Koong AC, Chen EY, Mivcchi NF. Denko NC, Stambrook P. Giaccia AJ: Hypoxic activation of nuclear factor-xB is mediated by a ras and raf signaling pathway and does not involve MAP kinase (erk-1 and erk-2). Cancer Res 1994;54:5273-5279.
144. Stevenson MA, Pollock SS. Coleman CN, Calderwood SK: X-irradiation, phorbol esters and HiOi stimulate mitogen-activated protein kinase activity in N1H/3T3 cells through the formation of reactive oxygen intermediates. Cancer Res 1994;54:12-15.
145. Hirose K, Ixingo DL, Oppenheim JJ, Matsushima K: Overexprcssion of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs and ionizing radiation. FASEB J 1993;7:361-368.
146. Petrovecki M, Präger A, Terry NHA. Murray D: Relationships between DNA damage and the survival of murine bone marrow cells irradiated in situ. Radiat Res 1994; 138:443-450.
147. Mundlc S, Payne G, Shetty V, Marcus B, Locw J, Shott S, Gregory S, Raza A: Contrasting patterns of proliferation and apoptosis in myelodysplastic syndromes and acute myelogenous leukemias. Exp Hematol 1994:22: 764.
148. Punjabi CJ. Laskin JD. Hwang SM. Mac Eachern L. Laskin DL: Enhanced production of nitric oxide by bone marrow cells and inreased sensitivity to macrophage colony-stimulating factor (CSF) and granulocyte-macrophage CSF after benzene treatment of mice. Blood 1994:83:3255-3263.
149. Van Zant G. Rummel SA. Roller MR, Larson DB, Drubachcvsky I, Palsson M, Emerson SG: Expansion in bioreactors of human progenitor populations from cord blood and mobilized peripheral blood. Blood Cells 1994:20: 482-491.
150. Verfaillic CM: Direct contact between human primitive hematopoietic progenitors and marrow stroma is not required for long term in vitro hcmatopoicsis. Blood 1992:79:2821-2826.
151. Muschel RJ, Bernhard EJ, Garza L, McKenna WG, Koch CJ: Induction of apoptosis at different oxygen tensions: Evidence that oxygen radicals do not mediate apoptotic signaling. Cancer Res 1995;55:995-998.
152. hl stem cells to bone marrow stroma. J Clin Invest 1992:90: 358-367.
153. Abkowitz JL, Linenbergcr ML, Persik M, Newton MA, Guttorp P: Behavior of feline hematopoietic stem cells years after busulfan exposure. Blood 1993;82:2096-2103.
154. Mauch P, Constine L, Greenberger JS, Knospe W, Sullivan J, Liesveld JL, Dccg HJ: Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy. Int J Radiat Oncol Biol Phys 1995;31:1319-1339.
155. Rafii S, Shapiro F, Rimarachin J, Nachman RL. Ferris B, Wekslcr B, Moore MAS. Asch AS: Isolation and characterization of human bone marrow microvascular endothelial cells: Hematopoietic progenitor cell adhesion. Blood 1994;84:10-19.
156. Goltry KL, Poguc-Gcilc KL, Greenberger JS: Indirect irradiation leukemogenesis through bone marrow stromal cells: Use of differential display to identify genes with altered expression in irradiated stromal cells or induced in FDC-P1 cells by cocultivation. Exp Hematol 1995,23:751.
157. Roecklein PA, Torok-Storb B: Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6/E7 genes. Blood 1995:85: 997-1005.
158. Epperly MW, Hallahan DE, Kufc DW, Wcichselbaum R, Greenberger JS: Expression of the MnSOD transgene increases the radiorcsistance of the 32D cl 3 hematopoietic progenitor cell line. Int J Radiat Oncol Biol Phys, submitted.
159. Martin M, Lcfaix JL, Pinton P, Crcchct F, Daburon F: Temporal modulation ofTGF-pl and P-actin gene expression in pig skin and muscular fibrosis after ionizing radiation. Radiat Res 1993;134:63-70.
160. McClave P, Verfaillie C, Miller J: Interaction of primitive human myeloid and lymphoid progenitors with the marrow microenvironment. Blood Cells 1994;20:121-128.
161. Yoshikubo T. Ozawa K. Takahashi K, Nishi-kawa M, Horiuchi N, Tojo A, Tani K, Koda-ma A, Asano S: Adhesion of NFS-60 myeloid leukemia cells to MC3T3-G2/PA6 stromal cells induces granulocyte colony-stimulating factor production. Blood 1994;84:415-420.
162. Uchiyama H. Barut BA. Mohrbacher AF, Chauhan D, Anderson KC: Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates intcrlcukin-6 secretion. Blood 1993;82:3712-3720.
163. Totsuka T, Tanimoto H, Yamaguchi T, Inoue H, Saito I, Miyasaka N: Invasive human T lymphoma cells produce a novel factor that uprcgulates expression of adhesion molecules on endothelial cells. Exp Hematol 1993;21: 1544-1549.
164. Makrynikola V. Bianchi A, Bradstock K, Gottlieb D. Hewson J: Migration of acute lymphoblastic leukemia cells into human bone marrow stroma. Leukemia 1994;8: 1734-1743.
165. Janiak M, Sawicki G, Janowska-Wieczorek A: Expression of pi integrin mRNAs in human leukemic blasts. Leukemia 1994;8: 1544-1550.
166. Kharbanda S, Saleem A, Datta R. Yuan ZM, Wcichselbaum R. Kufe D: Ionizing radiation induces rapid tyrosine phosphorylation of p34 fancer Res1994:54:1412-1414.
167. Kimura H, Wu N, Dodge R, Spencer DP, Klitzman B, McIntyre T, Dewhirst MW: Inhibition of radiation-induced upregulation of leukocyte adhesion to endothelial cells with the platelet activating factor inhibitor, BN5201. Int J Radiat Oncol Biol Phys 1994; 30S 1:219-227.
168. Hallahan DE, Blcakman D, Virudachalam S, Lee D, Grdina D, Kufe DW, Weichselbaum RR: The role of intracellular calcium in the cellular response to ionizing radiation. Radiat Res 1994;138:392-400.
169. Coombe DR, Watt SM, Parish CR: Mac-1 (CD11 b/CD 18) and CD45 mediate the adhesion of hematopoietic progenitor cells to stromal cell elements via recognition of stromal heparan sulfate. Blood 1994;84:739-752.
170. Hou J, Baichwa! V, Cao Z: Regulatory elements and transcription factors controlling basal and cytokine-induced expression of the gene encoding intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1994:91: 11641-11645.
171. Agarwal R, Doren S, Hicks B, Dunbar CE: Long-term culture of chronic myelogenous leukemia marrow cells on stem cell factor-deficient stroma favors benign progenitors. Blood 1995;85:1306-1312.
172. Letterio JJ, Geiser AG, Lucia S, Roberts AB, Sporn MB: Disrupted expression of transforming growth factor-pl in class II major histocompatibility antigen-dcficicnt mice leads to dysregulated hematopoiesis. Proc Am Assoc Cancer Res 1995;36:190.
173. Askew DS, Ihle JN, Cleveland JL: Activation of apoptosis with enforced myc expression in myeloid progenitor cells is dominant to the suppression of apoptosis by interleukin-3 or erythropoietin. Blood 1993;82:2079-2087.
174. Woloschak GE, Chang-Liu CM, Shearin-Jones P: Regulation of protein kinase C by ionizing radiation. Cancer Res 1990;50: 3963-3967.
175. Chen AR, Rohrschncidcr LR: Mechanism of differential inhibition of factor-dependent cell proliferation by transforming growth fac-tor-pi: Selective uncloupling of fins from myc.Blood 1993;81:2539-2546.
176. Bendall LJ, Kortlcpcl K, Gottlieb DJ: Human acute myeloid leukemia cells bind to bone marrow stroma via a combination of p-1 and p-2 integrin mechanisms. Blood 1993:82: 3125-3132.
177. Greenlund US, Deckwerth TL Jr., Johnson M: Superoxide dismutasc delays neuronal apoptosis: A role for reactive oxygen species in programmed neuronal death. Neuron 1995;14:303-315.
178. Greenberger JS: Methods for use of stromal cells for therapeutic gene delivery; in Robbins P (ed): Gene Therapy. Clifton. Humana, in press.
179. Verfaillie CM, Li WN, Catanzarro P: MIP-la combined with IL-3 maintains primitive human LTBMC-IC for at least 8 weeks in ex vivo ‘stroma-noncontact’ cultures. J Exp Med 1994;179:643-649.
180. Greenberger JS: Hematopoiesis; in Bcrtino JR (ed): Molecular Biology of Cancer. San Diego, Academic Press, in press.